At a glance

ClinicalIndex Comparison Record

Phase 3Completed

Drug / intervention

Buprenorphinedrug

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00078117

NCT00078117Phase 3Completed

Compare CT.gov

Suboxone: (Buprenorphine/Naloxone) Comparison of Two Taper Schedules

University of California, Los Angeles·interventional·Posted Feb 20, 2004·Updated Jan 12, 2017

In Brief

A Phase 3 clinical trial evaluating Buprenorphine for Opioid-Related Disorders. Completed, across 11 sites.

Detailed Summary

The purpose of this protocol is to to compare the clinical utility of two dosage tapering regimens in Buprenorphine/Naloxone stabilized subjects for opiate detoxification.

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsOpioid-Related Disorders

CountriesUnited States

Collaborators--

Timeline

Phase 3CompletedFinished

2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027

Enrollment StartJun 2003

First PostedFeb 2004

Primary CompletionMay 2005

TodayJul 2026

First PostedFeb 20, 2004

Enrollment StartJun 1, 2003

Primary CompletionMay 1, 2005

TodayJul 2, 2026

Enrollment to primary: 1.9 yearsPosted 22.4 years ago

Interventions

Buprenorphinedrug